Phase separation in phosphatidylcholine membrane caused by the presence of a pyrimidine analogue of fluphenazine with high anti-multidrug-resistance activity

Journal of Physical Chemistry B

Volumn 118, Issue 13, 2014, Pages 3605-3615

  Cieślik Boczula, Katarzyna ^a   Świa̧tek, Piotr ^b   Jaszczyszyn, Agata ^b   Zawilska, Patrycja ^a   Ga̧siorowski, Kazimierz ^b   Malinka, Wiesław ^b   Köhler, Gottfried ^c  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENUATED TOTAL REFLECTANCE; CHEMOTHERAPEUTIC AGENTS; DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; LAURDAN FLUORESCENCES; MULTIDRUG RESISTANCE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID MOLECULES; WORLD HEALTH ORGANIZATION;

DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; LIPID BILAYERS; LIPOSOMES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE SEPARATION; PHOSPHOLIPIDS;

AROMATIC COMPOUNDS;

ANTINEOPLASTIC AGENT; DIPALMITOYLPHOSPHATIDYLCHOLINE; FLUPHENAZINE; LIPID BILAYER; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN; NEUROLEPTIC AGENT; PHOSPHATIDYLCHOLINE; PHOSPHORUS; PYRIMIDINE DERIVATIVE;

CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; HUMAN; INFRARED SPECTROSCOPY; LIPID BILAYER; METABOLISM; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG RESISTANCE, MULTIPLE; FLUPHENAZINE; HUMANS; LIPID BILAYERS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; P-GLYCOPROTEIN; PHOSPHATIDYLCHOLINES; PHOSPHORUS; PYRIMIDINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84898071578     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp410882r     Document Type: Article

References (58)

1. Schmidt, M.; Teitge, M.; Castillo, M. E.; Brandt, T.; Dobner, B.; Langner, A. Synthesis and Biochemical Characterization of New Phenothiazines and Related Drugs as MDR Reversal Agents Arch. Pharm. (Weinheim, Ger.) 2008, 341, 624-638
2. Beck, T. W. The Cell Biology of Multiple Drug Resistance Biochem. Pharmacol. 1987, 36, 2879-2887
3. Bradleya, G.; Juranka, P. F.; Ling, V. Mechanism of Multidrug Resistance Biochim. Biophys. Acta 1988, 948, 87-128
4. Anuchapreeda, S.; Leechanachai, P.; Smith, M. M.; Ambudkar, S. V.; Limtrakul, P. Modulation of P-glycoprotein Expression and Function by Curcumin in Multidrug-Resistant Human KB Cells Biochem. Pharmacol. 2002, 64, 573-582
5. Velingkar, V. S.; Dandekar, V. D. Modulation of P-Glycoprotein Mediated Multidrug Resistance (MDR) in Cancer Using Chemosensitizers Int. J. Pharma Sci. Res. 2010, 1, 104-111
6. Rebucci, M.; Michiels, C. Molecular Aspects of Cancer Cell Resistance to Chemotherapy Biochem. Pharmacol. 2013, 85, 1219-1226
7. Ahn, E.-Y.; Pan, G.; Oh, J. H.; Tytler, E. M.; McDonalds, J. M. The Combination of Calmodulin Antagonists and Interferon-γ Induces Apoptosis Through Caspase-Dependent and -Independent Pathways in Cholangiocarcinoma Am. J. Pathol. 2003, 163, 2053-2063
8. Paja̧k, B.; Orzechowski, A. Overview How Adenocarcinoma Cancer Cells Avoid Immune- and Chemotherapy-Induces Apoptosis Adv. Med. Sci. 2006, 51, 39-45
9. Kónya, A.; Andor, A.; Sátorhelyi, P.; Németh, K.; Kurucz, I. Inhibition of the MDR1 Transporter by New Phenothiazine Derivatives Biochem. Biophys. Res. Commun. 2006, 346, 45-50
10. Duarte, N.; Ramalhete, C.; Varga, A.; Molnar, J.; Ferreira, M.-J. U. Multidrug Resistance Modulation and Apoptosis Induction of Cancer Cells by Terpenic Compounds Isolated From Euphorbia Species Anticancer Res. 2009, 29, 4467-4472
11. Chen, Y.; Simon, S. M. In Situ Biochemical Demonstration that P-Glycoprotein Is a Drug Efflux Pump With Broad Specificity J. Cell Biol. 2000, 148, 863-870
12. Maki, N.; Dey, S. Biochemical and Pharmacological Properties of an Allosteric Modulator Site of the Human P-Glycoprotein (ABCB1) Biochem. Pharmacol. 2006, 72, 145-155
13. Chadwick, B.; Waller, D. G.; Edwards, J. G. Potentially Hazardous Drug Interactions with Psychotropics Adv. Psychiatr. Treat. 2005, 11, 440-449
14. Jaszczyszyn, A.; Ga̧siorowski, K. Limitations of the MTT Assay in Cell Viability Testing Adv. Clin. Exp. Med. 2008, 17, 525-529
15. Ga̧siorowski, K.; Malinka, W.; Świa̧tek, P.; Jaszczyszyn, A. Antimutagenic Activity of New Analogues of Fluphenazine Cell. Mol. Biol. Lett. 2003, 8, 927-942
16. Jaszczyszyn, A.; Ga̧siorowski, K.; Świa̧tek, P.; Malinka, W.; Cieślik-Boczula, K.; Petrus, J.; Czarnik-Matusewicz, B. Chemical Structure of Phenothiazines and Their Biological Activity Pharmacol. Rep. 2012, 64, 16-23
17. Jaszczyszyn, A.; Ga̧siorowski, K.; Świa̧tek, P.; Malinka, W.; Cieślik-Boczula, K.; Petrus, J.; Czarnik-Matusewicz, B. New Fluphenazine Analogue as Inhibitors of P-Glycoprotein in Human Lymphocyte Cultures Contemp. Onkol. 2012, 16, 332-337
18. Gil-Ad, I.; Shtaif, B.; Levkovitz, Y.; Dayag, M.; Zeldich, E.; Weizman, A. Characterization of Phenothiazine-Induced Apoptosis in Neuroblastoma and Glioma Cell Lines J. Mol. Neurosci. 2004, 22, 189-197
19. Gil-Ad, I.; Shtaif, B.; Levkovitz, Y.; Nordenberg, J.; Taler, M.; Korov, I.; Weizman, A. Phenothiazines Induce Apoptosis in B16 Mouse Melanoma Cell Line and Attenuate in Vivo Melanoma Tumor Growth Oncol. Rep. 2006, 15, 107-112
20. Carey, S. S.; Gleason-Guzman, M.; Gokhale, V.; Hurley, L. H. Psorospermin Structural Requirements for P-Glycoprotein Resistance Reversal Mol. Cancer Ther. 2008, 7, 3617-3623
21. Dalton, S. O.; Johansen, C.; Poulsen, A. H.; Norgaard, M.; Sorensen, H. T.; McLaughalin, J. K.; Mortensen, P. B.; Friis, S. Cancer Risk Among Users of Neuroleptic Medication: A Population-Based Cohort Study Brit. J. Cancer 2006, 95, 934-939
22. Catts, V. S.; Catts, S. V.; O'Toole, B. I.; Frost, A. D. Cancer Incidence in Patients with Schizophrenia and Their First-Degree Relatives-A Meta-Analysis Acta Psychiatr. Scand. 2008, 117, 323-336
23. Ohlow, M. J.; Moosmann, B. Phenothiazine: The Seven Lives of Pharmacology's First Lead Structure (Foundation Review) Drug Discovery Today 2011, 16, 119-131
24. Poła, A.; Michalak, K.; Burliga, A.; Motohashi, N.; Kawase, M. Determination of Lipid/Bilayer/Water Partition Coefficient of New Phenothiazines Using the Second Derivative of Absorption Spectra Method Eur. J. Pharm. Sci. 2004, 21, 421-427
25. Hendrich, A. B.; Wesolowska, O.; Komorowska, M.; Motohashi, N.; Michalak, K. The Alterations of Lipid Bilayer Fluidity Induced by Newly Synthesized Phenothiazine Derivative Biophys. Chem. 2002, 98, 275-285
26. Hendrich, A. B.; Wesołowska, O.; Motohashi, N.; Molnar, J.; Michalak, K. New Phenothiazine-Type Multidrug Resistance Modifiers: Anti-MDR Activity Versus Membrane Perturbing Potency Biochem. Biophys. Res. Commun. 2003, 304, 260-265
27. Cieślik-Boczula, K.; Szwed, J.; Jaszczyszyn, A.; Ga̧siorowski, K.; Kol, A. Interactions of Dihydrochloride Fluphenazine with DPPC Liposomes: ATR-IR and 31P NMR Studies J. Phys. Chem. B 2009, 113, 15495-15502
28. Petrus, J.; Czarnik-Matusewicz, B.; Jaszczyszyn, A.; Ga̧siorowski, K.; Cieślik-Boczula, K.; Wesołowska, O.; Michalak, K.; Świa̧tek, P.; Malinka, W. Influence of Fluphenazine Dihydrochloride on Model Dipalmitoylphosphatidylcholine Membranes and Human Genotoxically Damaged Lymphocyte Cultures Pharmacia 2012, 25, 270-273
29. Yeagle, P. L. The Structure of Biological Membranes, 3 rd ed.; CRC Press: Boca Raton, FL, USA, 2012.
30. Andreani, A.; Rambaldi, M.; Locatelli, A.; Aresca, P.; Bossa, R.; Galatulas, I. Potential Antitumor Agents XVIII. Synthesis and Cytotoxic Activity of Phenothiazine Derivatives Eur. J. Med. Chem. 1991, 26, 113-116
31. Parasassi, T.; Krasnowska, E. K.; Bagatolli, L.; Gratton, E. Laurdan and Prodan as Polarity-Sensitive Fluorescent Membrane Probes J. Fluoresc. 1998, 8, 365-373
32. Parasassi, T.; Stasio, G.; dUbaldo, A.; Gratton, E. Phase Fluctuation in Phospholipid Membranes Revealed by Laurdan Fluorescence Biophys. J. 1990, 57, 1179-1186
33. Kitumara, K.; Imayoshi, N.; Goto, T.; Shiro, H.; Mano, T.; Makai, Y. Second derivative spectrophotometric detection of partition coefficients of chlorpromazine and promazine between lecithin bilayer vesicles and water Anal. Chim. Acta 1995, 304, 101-106
34. Poła, A.; Michalak, K.; Burliga, A.; Motohashi, N.; Kawase, M. Determination of Lipid Bilayer/Water Partition Coefficient of New Phenothiazines Using the Second Derivative of Absorption Spectra Method Eur. J. Pharm. Sci. 2004, 21, 421-427
35. Parasassi, T.; Stasio, G.; Ravagnan, G.; Rusch, R. M.; Gratton, E. Quantitation of Lipid Phases in Mixed Phospholipid Vesicles by Generalized Polarization of Laurdan Fluorescence Biophys. J. 1991, 60, 179-189
36. Cieślik-Boczula, K.; Petrus, R. M.; Köhler, G.; Lis, T.; Koll, A. Interaction of Piperidin Derivative of Mannich Base with DPPC Liposomes J. Phys. Chem. B 2013, 117, 2938-2946
37. Harris, F. M.; Best, K. B.; Bell, J. D. Use of Laurdan Fluorescence Intensity and Polarization to Distinguish Between Changes in Membrane Fluidity and Phospholipid Order Biochim. Biophys. Acta 2002, 1565, 123-128
38. Cullisa, P. R.; De Kruijff, B. Lipid Polymorphism and the Functional Roles of Lipids in Biological Membranes Biochim. Biophys. Acta 1979, 559, 399-420
39. Cieślik-Boczula, K.; Koll, A. The Effect of 3-Pentadecylphenol on DPPC Bilayers ATR-IR and 31P NMR Studies Biophys. Chem. 2009, 140, 51-56
40. Ashera, I. M.; Levin, I. W. Effects of Temperature and Molecular Interactions on the Vibrational Infrared Spectra of Phospholipid Vesicles Biochim. Biophys. Acta 1977, 468, 63-72
41. Cieślik-Boczula, K.; Maniewska, J.; Grynkiewicz, G.; Szeja, W.; Koll, A.; Hendrich, A. B. Interaction of Quercetin, Genistein and Its Derivatives with Lipid Bilayers-An ATR IR-Spectroscopic Study Vib. Spectrosc. 2012, 62, 64-69
42. Frenzel, J.; Arnold, K.; Nuhn, P. Calorimetric, 13C NMR, and 31P NMR Studies on the Interaction of Some Phenothiazine Derivatives with Dipalmitoyl Phosphatidylcholine Model Membranes Biochim. Biophys. Acta 1978, 507, 185-197
43. Hendrich, A. B.; Wesołowska, O.; Michalak, M. Trifluoperazine Induces Domain Formation in Zwitterionic Phosphatidylcholine but Not in Charged Phosphatidylglycerol Bilayers Biochim. Biophys. Acta 2001, 1510, 414-425
44. McElhaney, R. N.; Lewis, R. N. A. H. Fourier Transform Infrared Spectroscopy in the Study of Hydrated Lipids and Lipid Bilayer Membranes. In Infrared Spectroscopy of Biomolecules; Mantsch, H. H; Chapman, D., Ed.; Wiley Liss: New York, 1996; pp 159-202.
45. Ferté, J. Analysis of the Tangled Relationships Between P-Glycoprotein-Mediated Multidrug Resistance and the Lipid Phase of the Cell Membrane J. Eur. J. Biochem. 2000, 267, 277-294
46. Lu, P.; Liu, R.; Sharom, F. J. Drug Transport by Reconstituted P-Glycoprotein in Proteoliposomes. Effect of Substrates and Modulators, and Dependence on Bilayer Phase State Eur. J. Biochem. 2001, 268, 1687-1697
47. Wang, G.; Pincheira, R.; Zhang, J. T. Dissection of Drug Binding-Induced Conformational Changes in P-Glycoprotein Eur. J. Biochem. 1998, 255, 383-390
48. Sharom, F. J. The P-Glycoprotein Multidrug Transporter: Interactions with Membrane Lipids, and Their Modulation of Activity Biochem. Soc. Trans. 1997, 25, 1088-1096
49. Romsicki, Y.; Sharom, F. J. The ATPase and ATP-Binding Functions of P-Glycoprotein. Modulation by Interaction with Defined Phospholipids Eur. J. Biochem. 1998, 256, 170-178
50. Demeule, M.; Jodoin, J.; Gingras, D.; Beliveau, R. P-Glycoprotain is Localized in Caveolae in Resistant Cells and in Brain Capillaries FEBS Lett. 2000, 466, 219-224
51. Wesołowska, O.; Michalak, M.; Hendrich, A. B. Direct Visualization of Phase Separation Induced by Phenothiazine-Type Antipsychotic Drugs in Model Lipid Membranes Mol. Membr. Biol. 2011, 28, 103-114
52. Bensikaddour, H.; Snoussi, K.; Lins, L.; Bambeke, F.; Tulkens, P. M.; Brasseur, R.; Goormaghtigh, E.; Mingeot-Leclercq, M.-P. Interactions of Ciprofloxacin with DPPC and DPPG: Fluorescence Anisotropy, ATR-FTIR and 31P NMR Spectroscopies and Conformational Analysis Biochim. Biophys. Acta, Biomembr. 2008, 1778, 2535-2543
53. Fa, N.; Ronkart, S.; Schanck, A.; Deleu, M.; Gaigneaux, A.; Goormaghtigh, E.; Mingeot-Leclercq, M.-P. Effect of the Antibiotic Azithromycin on Thermotropic Behavior of DOPC or DPPC Bilayers Chem. Phys. Lipids 2006, 114, 108-116
54. Berquand, A.; Fa, N.; Dufrêne, Y. F.; Mingeot-Leclercq, M.-P. Interaction of the Macrolide Antibiotic Azithromycin with Lipid Bilayers: Effect on Membrane Organization, Fluidity, and Permeability Pharm. Res. 2005, 22, 465-475
55. Bensikaddour, H.; Fa, N.; Burton, I.; Deleu, L.; Lins, L.; Schanck, A.; Brasseur, R.; Dufrene, Y. F.; Goormaghtigh, E.; Mingeot-Leclercq, M.-P. Characterization of the Interactions between Fluoroquinolone Antibiotics and Lipids: A Multitechnique Approach Biophys. J. 2008, 94, 3035-3046
56. van Veen, H. W.; Konings, W. N. Multidrug Transporters from Bacteria to Man: Similarities in Structure and Function Semin. Cancer Biol. 1997, 8, 183-192
57. van Veen, H. W.; Putman, M.; Margolles, A.; Sakamoto, K.; Konings, W. N. Structure-Function Analysis of Multidrug Transporters in Lactococcus Lactis Biochim. Biophys. Acta 1999, 1461, 201-206
58. Jaszczyszyn, A.; Ga̧siorowski, K.; Świa̧tek, P.; Malinka, W.; Cieślik-Boczula, K.; Petrus, J.; Czarnik-Matusewicz, B. Analog in Chemoprevention of Late Cancer. In Live with Dignity to the End. Vol. 3: Clinical and Social Aspects of Palliative and Hospice Care; Krzyz̀anowski, D.; Krakowiak, P.; Binnebesel, J.; Fal, A. M.; Steciwko, A., Eds.; Publishing House WCM: Opole, Poland, 2011; pp 152-165.